Bavarian Nordic — Juni 2020
-
Zealand Pharma har siden grundlæggelsen i 1997 overordnet set specialiseret sig i produkter rettet mod diabetes, fedme samt tarmsygdomme.
Biotekselskabet har særligt tre præparater i pipelinen, som Frank Hørning hæfter sig ved. Det gælder et produkt til sænkning af blodsukkeret, et andet produkt rettet mod fedme samt et tredje produkt rettet mod korttarmssyndrom.
-
In addition to meeting with individual investors, both executives are scheduled to participate in a fireside chat with a research analyst on Thursday, June 4, 2020 from 11:00 to 11:25 AM Eastern. The presentation can be accessed at http://wsw.com/webcast/jeff126/zeal/
-
A replay of this presentation will be accessible via the same link, and will be available after the conference on the Companys website http://www.zealandpharma.com.
-
Test
-
-
Alt biotek får tæsk i dag - hvorfor?
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind